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Background: Whether skeletal effects are obtained by functional appliances in class II subjects is still controversial.
In this regard, most of the available studies did not clearly identify the growth phases (i.e. pubertal or not) of the
treated patients. This retrospective controlled study aimed at evaluating the skeletal and dental changes in class II
subjects produced by the functional regulator (FR)-2 treatment during the pre-pubertal growth phase.
Methods: The data were derived from records obtained at a university dental clinic. A total of 17 treated subjects
and a total of 17 untreated controls, all pre-pubertal, matched for malocclusion, age (8.8 ± 1.5 years) and sex
(18 females, 16 males), were included. The overall observational period was 1.6 ± 0.8 years for both groups.
Results: Only minor skeletal changes with very little clinical relevance were seen after the observational period.
Most of the changes produced by the FR-2 treatment were at the dental level including palatal tipping of the maxillary
incisors and slight proclination of the mandibular incisors, both accounting for the noteworthy overjet reduction.
Conclusions: The present study has shown that functional treatment of class II malocclusion by FR-2 appliance during
the pre-pubertal growth phase is limited to modification at the dental level.Background
class II is one of the most prevalent dental and skeletal
malocclusion in the sagittal plane, and it occurs in up to
one-third of the population [1,2], with the highest preva-
lence among northern European descent [1]. Although
variable combinations of dental and skeletal factors con-
tribute to this malocclusion, the most frequent diagnostic
finding in class II malocclusion is mandibular skeletal
retrusion [1,3]. A therapy able to enhance mandibular
growth is thus indicated in class II patients [4]. To this
goal, a wide range of functional appliances aimed to
stimulate mandibular growth by forward posturing of
the mandible is available [5]. Many treatment protocols,
sample sizes and research approaches have led to dis-
parate outcomes in studies on human subjects [5].
One of the very earlier available functional appliances
is the functional regulator (FR)-2 [6]. The FR-2 has been* Correspondence: G.Perinetti@fmc.units.it
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in any medium, provided the original work is pdeveloped to eliminate functional disorders that can inter-
fere with normal skeletal and dental development [6]. The
claimed mechanism of action of this appliance is targeting
poor postural behaviour of the orofacial musculature
and, in particular for class II malocclusion, advancing the
mandible with muscular training [6].
In spite of the number of studies on FR-2 treatment
performed to date, there are still controversial aspects
mainly regarding the skeletal effects provided by this
appliance [7]. In particular, a wide range of different results
has been reported, from no skeletal effects [8] to restriction
of the maxillary growth [9] or enhanced mandibular length
[3,10,11]. However, major limitations of most of these
previous investigations, which may account for the dif-
ferent conclusions carried out, have recently been un-
covered [7].
An important aspect in functional treatment for skeletal
class II malocclusion is the growth phase, i.e. pre-pubertal
or pubertal, at which treatment is delivered. Indeed, it
has been demonstrated how individual responsiveness
to treatment, especially in terms of mandible elongation,
is critically dependent on this aspect [12-14]. However,n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Perillo et al. Progress in Orthodontics 2013, 14:18 Page 2 of 8
http://www.progressinorthodontics.com/content/14/1/18studies on the FR-2 treatment have included patients
on the basis of dentition phase [3] or chronological age
[8-10,15].
Moreover, the request for early treatment in class II
patients has led to a common practice procedure according
to which functional treatment is performed during a pre-
pubertal growth phase. Therefore, considering important
clinical implications, the knowledge on whether or not
the FR-2 treatment may be effective in reducing class II
malocclusion by relevant skeletal changes when delivered
at the pre-pubertal growth phase would be useful. The
present controlled study was thus carried out to elucidate
on the skeletal and dental effects produced by a FR-2
treatment in subjects with skeletal class II malocclusion
and treated during the pre-pubertal growth phase.
Methods
Subjects and study design
This study followed a retrospective, longitudinal, single-
blind design. An initial sample of 128 subjects seeking
orthodontic treatment, who had never been treated before
and presenting at the Section of Orthodontics of the
Department of Oral Sciences, Second University of
Naples, was screened. As a routine procedure, a signed
informed consent to release diagnostic records for scien-
tific purposes was obtained from the parents of the sub-
jects prior to entry into the treatment. Other inclusion
criteria were as follows: (1) skeletal class II malocclusion
by mandibular retrusion, (2) good general health with
no growth or nutritional problems, (3) European (white)
ancestry, (4) absence of major craniofacial or dental
anomalies and (5) availability of pre-treatment and post-
treatment records all during the pre-pubertal growth
phase.
Class II division 1 malocclusion was strictly diagnosed
at baseline according to the following signs [10,16,17]:
full- or half-cusp class II molar relationship, excessive
overjet (>4 mm), skeletal sagittal relationship of class II
(ANB angle > 4°), mandibular retrusion (SNB angle < 78°)
and no maxillary protrusion (SNA angle > 84°). Sub-
jects who refused to be treated at the initial visit but
re-presented later were included in the control group
whenever a second set of diagnostic recording was
available. After this selection, 34 subjects (18 females
and 16 males, mean age 8.8 ± 1.5 years), 17 treated and
17 untreated controls, were included in the study.
Observational term and treatment
Lateral cephalograms were taken at two time periods re-
ferred to as T0 (baseline) and T1 (end of observational
term). At T0, the mean ages were 8.9 ± 1.1 years for the
treated group and 8.9 ± 1.8 years for the untreated con-
trol group. At T1, the mean ages were 10.4 ± 1.1 years
for the treated group and 10.5 ± 2.0 years for theuntreated control group. The treatment/observational
period was 1.6 ± 0.8 years for both groups.
The FR-2 appliances were constructed according to
the design recommended by Fränkel and Fränkel [6] with
an initial mandibular advancement that did not exceed
about 3 mm, followed by subsequent step-by-step advance-
ment of the same entities. After FR-2 treatment, care was
taken to ensure that the mandible could not be retruded
clinically, e.g. dual bite. Treatment was interrupted when a
class I molar relationship was achieved.
To discriminate between the lack of effect due to the
treatment protocol and poor patients' compliance, only
those who declared to have worn the appliance for at
least 18 h a day during the first 12 months of the treat-
ment were selected herein [10]. This judgment was based
on routine reports from parents of the patients. The ini-
tial lateral cephalogram was obtained not earlier than 4
months before the onset of the FR-2 treatment, and the
final one was obtained not later than 2 months after the
end of treatment.Assessment of the pre-pubertal growth phase
Pre-pubertal growth phase was assessed through the third
middle phalanx maturation (MPM) method [18]. The
MPM method as proposed herein comprises five stages
(MPS), of which stages 1 and 2 are present in the pre-
pubertal subjects and were briefly defined as follows:
MPS1 is when the epiphysis is narrower than the
metaphysis or when the epiphysis is as wide as the
metaphysis but with both tapered and rounded lateral
borders. The epiphysis and metaphysis are not fused.
This stage was described to be attained more than 1
year before the onset of the pubertal growth spurt [13].
MPS2 is when the epiphysis is at least as wide as the
metaphysis with sides of increasing thickness and show-
ing a clear line of demarcation at right angle. In case of
asymmetry between the two sides, e.g. one typical of MPS2
and the other less mature, the former is used to assign the
stage. This stage was described to be attained 1 year before
the onset of the pubertal growth phase [13,19].
All the included subjects had to show an MPS1 or
MPS2 at T1.Cephalometric analysis
A customised digitization regimen and analysis with ceph-
alometric software (Viewbox, version 3.0, dHAL Software,
Kifissia, Greece) was used for all cephalograms exam-
ined in this study. The cephalometric analysis required
the digitization of 17 landmarks. The customised cephalo-
metric analysis included measurements from the analyses
of Steiner [20], Jacobson [21] and McNamara [22], gener-
ating 17 variables, eight angular and nine linear, for each
tracing (Figure 1). Lateral cephalograms of both treated
Figure 1 Landmarks, distances and planes used in the
chephalometric analysis. Planes of reference: FH, Frankfurt
horizontal plane; NL, nasal line; ML, mandibular line; FOP, functional
occlusal plane; N perp, line on N perpendicular to the FH.
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to magnification factor (8%).
All sets of cephalograms were traced at the same time
by a blind operator. A preliminary tracing was made for
each film in the series, with particular attention to tracing
the outlines of the maxilla and the mandible, including the
mandibular condyle. A second blind investigator checked
each tracing for accuracy. Individual changes were expressed
as total, i.e. not annualised.Sample size calculation and method error analysis
A sample size of at least 17 subjects per group was ne-
cessary to detect an effect size (ES) coefficient [23] of 1.0
for each cephalometric parameter in the comparison be-
tween the groups at T1, with an alpha set at 0.05 and a
power of 0.8 [24]. The ES coefficient is the ratio of the
difference between the recordings of the two groups,
divided by the within-subject standard deviation (SD).
In particular, the ES coefficient has been defined as the
ratio of the difference between the mean changes of the
two groups divided by the corresponding weighted SDs.
A threshold of 0.8 [23] or 1.0 [25] has been reported to
be indicative of a clinically relevant effect.
With the aim of quantifying the full method error of
the recordings for each cephalometric parameter, the
method of moments variance estimator was used [26,27].
This variance estimator has the advantages of not being af-
fected by any unknown bias, i.e. systematic errors, betweenpairs of measurements [27]. This analysis was performed
on 20 pairs of recordings randomly selected.
Statistical analysis
The SPSS software, version 13.0 (SPSS® Inc., Chicago,
IL, USA) and Comprehensive Meta-Analysis, version 2
(BiostatTM, Englewood, NJ, USA) were used to perform
the statistical analyses. After having tested the normality
of the data with the Shapiro-Wilk test and the equality
of variance among the datasets using a Levene test,
non-parametric methods were used for data analysis.
Nevertheless, data were summarised as mean ± SD. For
each of the cephalometric parameters, a Wilcoxon test
and a Mann–Whitney U test were used to test the sig-
nificance of the differences between the time points
within each group and between the two groups within
either time point, respectively.
For both treated and untreated control groups, the
total changes for all cephalometric variables between T1
and T0 were computed. The significance of the differences
in these changes between the groups was also evaluated
by the Mann–Whitney U test. Finally, the changes seen
in the treated group subtracted by the corresponding
ones seen in the untreated control group were referred
to as the ‘treatment effect’, and for these, the ES coeffi-
cients along with the 95% confidence intervals (CIs)
were calculated, as previously described [28].
Briefly, the ES coefficients have been calculated to
assess the results in terms of statistically and/or clinic-
ally significant differences. In particular, the ES coefficient
has been defined as the ratio of the difference between
the mean changes of the two groups divided by the cor-
responding weighted SDs. Even though a threshold of
0.2 [23] has been reported to be indicative of the min-
imal value to assess the existence of a ‘small effect’,
herein the null hypothesis for the ES coefficient was to
be equal to zero, i.e. when the 95% CI includes the zero
value, then ‘no treatment effect’ was assessed. A p <0.05
was used to reject the null hypothesis.
Results
The errors for linear measurements ranged from 0.4
(overjet) to 0.9 mm (Pg to N perp); the errors for angu-
lar measurements varied from 0.4° (ANB angle) to 1.1°
(FH/ML angle). All results regarding the cephalometric
skeletal parameters are summarised in Table 1. In com-
parisons between the groups, none of the differences
between the values were statistically significant at either
T0 or T1, with the exception of the ANB angle recorded
at T1 that was significantly lower in the treated group.
In comparisons over time, within each group, condylion-A
(Co-A), condylion-gnathion (Co-Gn) and maxillo-mandibular
length (Max-Mand) difference underwent significant in-
creases in both the treated and untreated control groups
Table 1 Chephalometric skeletal parameters of the groups and corresponding changes (n = 17 per group)
Parameter Group Time point Changes ES coefficient
T0 T1
Maxillary
SNA angle (°) Treated 80.6 ± 2.4 80.2 ± 2.5 −0.4 ± 1.3 0.1 (−0.6-0.7)
Control 79.8 ± 2.7 79.5 ± 2.8 −0.3 ± 1.5
Difference NS NS NS NS
A to N perp (mm) Treated 1.8 ± 2.5 1.1 ± 2.9 −0.7 ± 1.6 0.2 (−0.5-0.8)
Control 2.2 ± 2.5 1.8 ± 2.9 −0.4 ± 1.6
Difference NS NS NS NS
Co-A (mm) Treated 85.1 ± 3.8 87.6 ± 4.3* 2.5 ± 1.9 0.2 (−0.4-0.9)
Control 82.7 ± 3.2 84.7 ± 3.8* 2.0 ± 2.1
Difference NS p < 0.05 NS NS
Mandibular
SNB angle (°) Treated 74.2 ± 2.0 74.7 ± 2.3** 0.5 ± 1.0 0.1 (−0.6-0.7)
Control 73.6 ± 2.2 74.0 ± 2.5 0.4 ± 1.2
Difference NS NS NS NS
Pg to N perp (mm) Treated −6.9 ± 3.9 −7.3 ± 4.5 −0.4 ± 2.0 0.3 (−0.4-0.9)
Control −5.0 ± 3.4 −4.8 ± 4.8 0.2 ± 2.1
Difference NS NS NS NS
Co-Gn (mm) Treated 103.6 ± 4.6 107.7 ± 5.3*** 4.1 ± 2.2 0.0 (−0.6-0.7)
Control 101.9 ± 4.4 105.9 ± 6.2*** 4.0 ± 3.0
Difference NS NS NS NS
Maxillo-mandibular
ANB angle (°) Treated 6.5 ± 1.5 4.8 ± 0.9*** −1.7 ± 1.2 0.8 (−0.1-1.5)
Control 6.2 ± 1.2 5.5 ± 1.1 −0.7 ± 1.3
Difference NS NS p < 0.05 p < 0.05
Wits (mm) Treated 3.8 ± 1.2 2.4 ± 1.3* −1.4 ± 1.1 0.1 (−0.6-0.8)
Control 3.1 ± 0.8 2.0 ± 2.6 −1.2 ± 2.5
Difference NS NS NS NS
Max-Mand difference (mm) Treated 18.4 ± 3.3 20.0 ± 2.9*** 1.6 ± 1.4 0.3 (−0.4-0.9)
Control 19.2 ± 2.7 21.3 ± 4.3* 2.1 ± 2.1
Difference NS NS NS NS
Vertical
FH-palatal plane angle (°) Treated −2.9 ± 3.4 −2.3 ± 3.8 0.6 ± 1.2 0.4 (−0.3-1.1)
Control −4.6 ± 3.1 −4.5 ± 2.8 0.1 ± 1.3
Difference NS NS NS NS
FH-mandibular plane angle (°) Treated 22.5 ± 4.9 22.2 ± 5.1 −0.3 ± 1.1 0.4 (−0.3-1.1)
Control 22.2 ± 4.9 22.5 ± 4.6 0.2 ± 1.3
Difference NS NS NS NS
Palatal plane-mandibular plane (°) Treated 25.4 ± 3.1 24.4 ± 3.0** −0.9 ± 1.3 0.6 (−0.0-1.3)
Control 26.8 ± 5.3 26.9 ± 4.9 0.1 ± 1.7
Difference NS NS NS NS
Data are presented as mean ± SD or mean (95% confidence interval). For the ES coefficient, the null hypothesis is to be equal to zero. NS, difference not
statistically significant. Significant differences with the corresponding baseline value: *p < 0.01, **p < 0.05, ***p < 0.001.
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angle underwent a slight (0.5°) but significant (p < 0.05)
increase, and the ANB angle, Wits and NL/ML angle
underwent a significant reduction of 1.7°, 1.4 mm and 0.9°,
respectively (p < 0.05, at least). Moreover, the changes
seen over time in the two groups were not significantly
different for any parameter, with the exception of the ANB
angle that underwent a greater reduction in the treated
group (treatment effect, 1.0°, p < 0.05). The ES coefficients
for the treatment effects were all not significantly different
than zero, except for the ANB angle that was 0.8 (95% CI,
0.1-1.5).
All results regarding the cephalometric dental parame-
ters are summarised in Table 2. In comparisons between
the groups, none of the differences between the values
were statistically significant at T0. On the contrary, at
T1, molar relationship and L1/ML angle were signifi-
cantly greater in the treated group (p < 0.001), while the
overjet was significantly lower, again, in the treated group
(p < 0.05). No significant differences were seen for the
U1/FH angle and overbite. In comparisons over time,
no significant differences were seen for the untreated
control group, while in the treated group, the molar re-
lationship and L1/ML angle underwent a significant
increase (p < 0.01), and the U1/FH angle and overjet
underwent a significant decrease (p < 0.01, at least). More-
over, the changes seen over time in the two groups were
all significantly different for any parameter, with the
exception of the L1/ML angle and overbite. In particu-
lar, these changes were greater in the treated group for
molar relationship and L1/ML angle (treatment effect,Table 2 Chephalometric dental parameters of the groups and
Parameter Group Time point
T0
Molar relationship (mm) Treated −1.3 ± 1.7
Control −1.8 ± 1.7
Difference NS
U1/FH angle (°) Treated 116.6 ± 5.7
Control 113.0 ± 9.3
Difference NS
L1/Mandibular plane angle (°) Treated 98.5 ± 5.7
Control 95.4 ± 5.7
Difference NS
Overjet (mm) Treated 8.3 ± 1.5
Control 7.5 ± 2.1
Difference NS
Overbite (mm) Treated 2.8 ± 1.6
Control 3.6 ± 1.9
Difference NS
Data are presented as mean ± SD or mean (95% confidence interval). For the ES co
statistically significant. Significant difference with the corresponding baseline value:1.8 mm, p < 0.01, at least) and lower in the treated
group for U1/FH angle and overjet (treatment effect,
5.3° and 2.9 mm, respectively, p < 0.01, at least). In par-
ticular, the changes seen in the L1/ML angle yielded a
treatment effect of 2.8°, although not significantly dif-
ferent between the groups. The ES coefficients for the
treatment effects were all significantly different than
zero, except that for the overbite. These significant ES
coefficients ranged from 0.7 to the 2.1 for the L1/ML
angle and overjet, respectively.
Discussion
Through a strict selection of subjects with skeletal class
II malocclusion, the present controlled study addressed
what the skeletal and dental effects produced by FR-2
treatment delivered at a pre-pubertal growth phase are.
The present results show clinically irrelevant skeletal ef-
fects and more pronounced dental changes, especially at
the incisors, mainly responsible for the reduction of the
overjet. Among the incisors, the maxillary ones under-
went more relevant positional changes.
One of the most critical aspects in functional treat-
ment of class II patients relates to the possibility of en-
hancing mandibular growth to a clinically relevant level.
Ideally, this growth should be restored to be comparable
to that of class I subjects [5,29]. In spite of the great
number of investigations performed over the last decades
[5], most of these were significantly hampered by the
designs used [30]. Among the main limitations are im-
proper diagnosis of skeletal class II malocclusion [30]
and the lack of evaluation of the growth phase duringcorresponding changes (n = 17 per group)
Changes ES coefficient
T1
0.9 ± 1.5* 2.2 ± 2.2 1.0 (0.3-1.7)
−1.4 ± 1.7 0.4 ± 1.1
p < 0.001 p < 0.01 p < 0.01
112.8 ± 5.9* −3.8 ± 3.7 1.1 (0.4-1.8)
114.6 ± 8.2 1.5 ± 5.3
NS p < 0.01 p < 0.01
101.8 ± 5.1* 3.3 ± 3.5 0.7 (0.0-1.3)
95.9 ± 4.8 0.5 ± 4.8
p < 0.001 NS p < 0.05
5.3 ± 1.4** −3.1 ± 1.3 2.1 (1.3-2.9)
7.3 ± 2.4 −0.2 ± 1.4
p < 0.05 p < 0.001 p < 0.01
3.7 ± 1.5 0.9 ± 2.1 0.2 (−0.5-0.8)
4.2 ± 1.5 0.6 ± 1.4
NS NS NS
efficient, the null hypothesis is to be equal to zero. NS, difference not
*p < 0.01, **p < 0.001.
Figure 2 Treatment effects on main sagittal skeletal parameters.
Treatment effects refer to the difference in mean changes between
the time points of the treated and untreated control groups. None
of the mean values reported (+0.5 mm (Co-A), +0.1 mm (Co-Gn),
−0.3 mm (A to N perp) and +0.6 mm (Pg to N perp)) were in the
range of the method error and not statically significant when
expressed as effect size coefficient.
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effects of FR-2 in growing class II patients are within
these general limitations and with few exceptions [11,12],
with a previous meta-analysis [7] that could not clearly
discriminate between true treatment effects due to FR-2
wearing and those due to other confounding factors, such
as the growth phase at which treatment was delivered.
The present study, even though used a retrospective
design, followed a rigorous classification of the class II
patients and selected a well-matched control group. For
both groups, the whole observational term was within
the pre-pubertal growth phase. Having the class II patients
included herein characterised by a retruded mandible, the
main issue to be addressed is whether or not this treat-
ment protocol is able to enhance mandibular growth on
the sagittal plane. In this regard, total mandibular length
measured by the Co-Gn (or Co-Menton/Pogonion) dis-
tance is a primary parameter. However, one of the major
confounding problems in cephalometrics is the use of
both Co and Articulare (Ar) as the posterior end point in
measuring mandibular total length. Indeed, measurements
with Ar as an end point, such as Ar-Gn, might give signifi-
cant values for supplementary mandibular growth, with-
out a corresponding increase in Co-Gn [15]. In spite of
this consideration, several of the previous investigations
on functional treatment for class II patients used Ar as
the posterior mandibular end point when dealing with
different class II appliances [5] or specifically regarding
the FR-2 [7]. In the present investigation, the total man-
dibular length, as Co-Gn, underwent very similar mean
increases of 4.1 and 4.0 mm in either the treated and
control groups, respectively. Similar results with no or
minimal effects of FR-2 treatment on mandibular length
(as Co-Gn or Co-Pogonion) were seen by previous in-
vestigations [15,32,33]. However, these studies did not
specify which growth phase the patients had during
treatment [15,32,33] or had an unmatched control group
[15]. On the contrary, McNamara et al. [3] reported a sup-
plementary increment of 3.6 mm/2 years in mandibular
length (Co-Gn) in patients treated in the late mixed and
early permanent dentitions, presumably with several of
these patients treated during the pubertal growth phase.
Petrovic et al. [12] reported an additional increase in
Co-Pogonion ranging from 0.8 to 5.5 mm/year depend-
ing on different biological growth categories in subjects
treated with the FR-2 at the pubertal growth phase.
Freeman et al. [11] reported a total increase in Co-Gn of
3.0 mm in subjects treated by FR-2 as compared to un-
treated controls over a 10-year-long follow-up. These
subjects showed a pre-pubertal and a post-pubertal growth
phase at the beginning and end of the treatment, respect-
ively [11].
In the present study, the treatment effect of FR-2 on
the skeletal growth of both the maxilla and mandiblewas insignificant (Table 1). With the exception of the
significant reduction in the ANB angle, all of the other
sagittal and vertical parameters showed very similar values
between the treated and untreated control groups. Par-
ticularly, the ES coefficients were generally low and not
significantly different than zero (Table 1). The main treat-
ment effects on the sagittal growth of the maxilla and the
mandible are shown in Figure 2. The treatment effects on
Co-A and Co-Gn distances were 0.5 and 0.1 mm, respect-
ively. Similarly, the treatment effects on the maxillary and
mandibular positions on the sagittal plane, referred to as
the A to N perp and Pg to N perp distances, respectively,
were also insignificant (+0.3 and +0.6 mm, respectively,
Figure 2). These changes were also within the range of the
method errors. The previous evidence mentioned above
and the present results may thus be explained by the
differences in the growth phase at which the patients
received treatment. The present controlled study is the
only one treating all the patients with FR-2 appliance
during the pre-pubertal growth phase. However, pre-
pubertal growing patients have been investigated in
randomised clinical trials [34,35] using different functional
appliances, although in those studies how the diagnosis
of skeletal class II malocclusion was appraised was not
clearly reported [36], or they relied on an increased
overjet [35] or molar class II (any subdivision) [34] that
cannot account for a true skeletal disharmony when used
alone [30]. In this regard, the identification of skeletal
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growth phase, would have major clinical implications
when dealing with orthodontic treatment in growing
patients with skeletal class II malocclusion [12-14].
Nevertheless, the patients treated herein underwent a
noteworthy reduction of the overjet and an improve-
ment of the molar relationship of 2.9 and 1.8 mm, re-
spectively (Table 2). These were, however, due to dental
effects produced by the FR-2 treatment. Indeed, a remark-
able palatal tipping of the maxillary incisors was seen
with a treatment effect on the U1/FH angle of 5.3°. On
the other hand, a proclination of the lower incisors was
also seen, although only the ES coefficient (0.7), and not
the treatment effect on the L1/ML angle (2.8°), was signifi-
cant. By using different parameters, very similar results
have been recorded in previous studies treating patients
at the pubertal growth phase [11], late mixed dentition
[3] or an unspecified growth/dentition phase [33,37,38].
Although Fränkel and Fränkel [6] reported only the
insignificant or minimal effects of the FR-2 treatment
on the tipping and position of the maxillary and man-
dibular incisors, all of these evidence would support
the concept that FR-2 treatment produced relevant dental
effects especially at the incisor level. These dental effects
would occur irrespective of the growth phase at which
treatment is delivered.
Therefore, considering the lack of skeletal effects by
FR-2 treatment and that dental compensation to reduce
the overjet may be obtained by a shorter period of fixed
appliance therapy, this latter option would be of choice
for all pre-pubertal class II subjects with prominent maxil-
lary incisors. This fixed orthodontic treatment, e.g. 2 × 4
appliance, would thus prevent incisor trauma [39], while
functional treatment for skeletal growth restoration
could be delayed until the onset of the pubertal growth
spurt [12-14].
Conclusions
The FR-2 treatment does not have relevant skeletal ef-
fects on class II patients treated during the pre-pubertal
growth phase, while the overjet reduction is mainly due
to dental effects.
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